Spots Global Cancer Trial Database for Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism
Official Title: Microparticle's Procoagulant Activity to Identify Patients With Cancer and a High Risk for Venous Thrombosis
Study ID: NCT02095925
Interventions
Study Description
Brief Summary: Cancer patients are at increased risk of deep venous thrombosis and pulmonary embolism, collectively termed venous thromboembolism (VTE). Risk assessment scores for VTE in cancer patients have been previously developed by the groups of Khorana and Vienna CATS. However, routine thromboprophylaxis for ambulatory cancer patients based on these scores is currently not recommended. In the investigators prospective, observational cohort study, the investigators aim to identify cancer patients at high risk for VTE based on clinical characteristics, coagulation biomarkers and the coagulant activity of tissue factor bearing microparticles.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hopital Louis Mourier, Colombes, Ile-de-France, France
Hospital D'Annunziata, Chieti, , Italy
Instituto Nacional de Cancerología, Mexico City, , Mexico
Slotervaart hospital, Amsterdam, Noord-Holland, Netherlands
VU medical center, Amsterdam, Noord-Holland, Netherlands
Academic Medical Center, Amsterdam, Noord-Holland, Netherlands
University Medical Center Groningen, Groningen, , Netherlands
Contact Details
Name: Harry R Buller, MD PhD
Affiliation: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
